Progesterone crosstalks with insulin-like growth factor signaling in breast cancer cells via induction of insulin receptor substrate-2 (original) (raw)

References

• Baserga R . (1995). Cancer Res., 55, 249–252.
• Bruning JC, Winnay J, Cheatham B and Kahn CR . (1997). Mol. Cell Biol., 17, 1513–1521.
• Chang Q, Li Y, White MF, Fletcher JA and Xiao S . (2002). Cancer Res., 62 (21), 6035–6038.
• Dupont J and Le Roith D . (2001). Mol. Pathol., 54, 149–154.
• Graham JD and Clarke CL . (1997). Endocr. Rev., 18, 502–519.
• Groshong SD, Owen GI, Grimison B, Schauer IE, Todd MC, Langan TA, Sclafani RA, Lange CA and Horwitz KB . (1997). Mol. Endocrinol., 11, 1593–1607.
• Jackson JG, White MF and Yee D . (1998). J. Biol. Chem., 273, 9994–10003.
• Kastner P, Krust A, Turcotte B, Stropp U, Tora L, Gronemeyer H and Chambon P . (1990). EMBO J., 9, 1603–1614.
• Lange CA, Richer JK, Shen T and Horwitz KB . (1998). J. Biol. Chem., 273, 31308–31316.
• Lapidus RG, Nass SG and Davidson NE . (1998). J. Mamm. Gland Biol. Neoplasia, 3, 85–94.
• Lee AV, Jackson JG, Gooch J L, Hilsenbeck SG, Coronado-Heinsohn E, Osborne CK and Yee D . (1999). Mol. Endocrinol., 13, 787–796.
• Lee AV and Yee D . (1995). Biomed. Pharmacother., 49, 415–421.
• LeRoith D . (1996). Baillieres Clin. Endocrinol. Metab., 10, 49–73.
• Lin VC, Ng EH, Aw SE, Tan MG, Chan VS and Ho GH . (1999). Clin. Cancer Res., 5, 395–403.
• Musgrove EA, Lee CS and Sutherland RL . (1991). Mol. Cell. Biol., 11, 5032–5043.
• Oesterreich S, Zhang P, Guler RL, Sun X, Curran EM, Welshons WV, Osborne CK and Lee AV . (2001). Cancer Res., 61, 5771–5777.
• Richer JK, Jacobsen BM, Manning NG, Abel MG, Wolf DM and Horwitz KB . (2002). J. Biol. Chem., 277, 5209–5218.
• Rocha RL, Hilsenbeck SG, Jackson JG, VanDenBerg CL, Weng C, Lee AV and Yee D . (1997). Clin. Cancer Res., 3, 103–109.
• Ross RK, Paganini-Hill A, Wan PC and Pike MC . (2000). J. Natl. Cancer Inst., 92, 328–332.
• Rossouw JE, Anderson GL, Prentice RL, LaCroix AZ, Kooperberg C, Stefanick ML, Jackson RD, Beresford SA, Howard BV, Johnson KC, Kotchen JM and Ockene J . (2002). JAMA, 288, 321–333.
• Schairer C, Lubin J, Troisi R, Sturgeon S, Brinton L and Hoover R . (2000). JAMA, 283, 485–491.
• Shaw LM . (2001). Mol. Cell. Biol., 21, 5082–5093.
• Surmacz E and Burgaud JL . (1995). Clin. Cancer Res., 1, 1429–1436.
• Vassen L, Wegrzyn W and Klein-Hitpass L . (1999). Mol. Endocrinol., 13, 485–494.
• Vegeto E, Shahbaz MM, Wen DX, Goldman ME, O'Malley BW and McDonnell DP . (1993). Mol. Endocrinol., 7, 1244–1255.
• Wen DX, Xu YF, Mais DE, Goldman ME and McDonnell DP . (1994). Mol. Cell. Biol., 14, 8356–8364.
• Yenush L and White MF . (1997). BioEssays, 19, 491–500.

Download references